See the DrugPatentWatch profile for vocabria
What is Rekambys (vocabria)?
Rekambys is a brand name for cabotegravir, a medicine used to treat HIV. Cabotegravir blocks HIV from establishing infection in the body by interfering with HIV’s ability to integrate its genetic material. [1]
What is the connection to Vocabria?
Vocabria is another brand name for cabotegravir (the same active ingredient). So “Rekambys vocabria” typically refers to the fact that these products are based on cabotegravir and are used for similar HIV treatment approaches. [1]
How is cabotegravir used for HIV treatment or prevention?
Cabotegravir is used in HIV care in a long-acting strategy (often alongside rilpivirine in combination regimens), where medication doses are spaced out rather than taken every day. The exact regimen depends on whether it is being used as part of treatment vs prevention and on the prescriber’s plan. [1]
What should patients ask their clinician about?
Patients usually want to confirm:
- whether the goal is long-acting treatment using cabotegravir (and possibly rilpivirine) or another strategy
- the dosing schedule for their specific regimen
- how injections are given and what to do if a dose is missed
- potential drug interactions and side effects
Your prescribing clinician or clinic can give the most specific guidance for your local product and dosing schedule. [1]
Where to check the exact product and prescribing details
Because brand names and indications can vary by country, the most reliable source is the local product’s prescribing information (or your pharmacist). That will list the active ingredient, approved uses, dosing schedule, and warnings for the specific “Rekambys” or “Vocabria” version you have. [1]
Sources
- https://www.ema.europa.eu/en/medicines/human/EPAR/vocabria